Results 151 to 160 of about 93,945 (299)
Safety of neoadjuvant radiotherapy or chemoradiotherapy combined with immunotherapy across solid tumors: Systematic review and meta-analysis protocol. [PDF]
Tahir I +3 more
europepmc +1 more source
Early detection of myocardial injury in cancer patients remains challenging with conventional diagnostic tools. 18F‐FAPI‐04 PET/CT revealed abnormal myocardial uptake associated with cardiovascular risk factors and biomarkers. 18F‐FAPI‐04 PET/CT enables early, noninvasive detection of myocardial injury, providing additional clinical value beyond cancer
Jing Jia +6 more
wiley +1 more source
Analysis of real-world clinical outcomes of perioperative chemotherapy compared to preoperative chemoradiotherapy in esophagogastric adenocarcinoma. [PDF]
Oyenuga M +10 more
europepmc +1 more source
Shuai Zhang, Liya Zhou, Xiaopeng Huang, Shaomin Lin Department of Radiation Oncology, Hainan General Hospital, Haikou 570311, Hainan, China Introduction: The purpose of this study was to analyze the efficacy and safety of concurrent chemoradiotherapy ...
Zhou L, Lin S, Huang X, Zhang S
core
ABSTRACT Background Sinonasal malignancies with orbital involvement may be managed with orbit‐sacrificing or orbit‐preserving surgical approaches, with a recent shift towards orbital preservation to reduce postoperative morbidity while maintaining oncological success.
Claire Jing‐Wen Tan +9 more
wiley +1 more source
Prophylactic cranial irradiation versus active MRI surveillance for limited-stage small-cell lung cancer achieving response after chemoradiotherapy: a protocol for a randomized, controlled, multicenter, phase III trial. [PDF]
Wei Z, Chen Y, Yu J, Meng X.
europepmc +1 more source
ABSTRACT With the approval of immunotherapies by regulatory bodies, head and neck squamous cell carcinoma (HNSCC) treatment has been revolutionized, and anti‐programmed cell death‐1 (anti‐PD‐1) agents are now the standard for platinum‐resistant recurrent/metastatic HNSCC.
Xiao‐Tong Yan +2 more
wiley +1 more source

